{
  "slug": "acquired-vision-loss",
  "question": "What are the odds of losing significant vision in a lifetime?",
  "category": "health",
  "tags": [
    "elder-care"
  ],
  "no_reliable_estimate": false,
  "perceived": {
    "description": "Vision loss is broadly understood as an aging risk — most adults know that cataracts, macular degeneration, and glaucoma exist, and that \"your eyes get worse\" is a thing that happens. The specific personal odds, though, almost never get quoted. Ask a typical under-60 reader to guess their lifetime probability of ending up with significant vision impairment and the median answer clusters well under 1 in 20, when the realistic US figure is roughly 1 in 10 and the global figure for anyone who reaches old age is closer to 1 in 7. The fear is culturally present but numerically vague.\n",
    "rough_estimate": "Most adults estimate their personal lifetime risk at well under 1 in 20",
    "kind": "intuition"
  },
  "native": {
    "display": "~2.2 billion people globally have a near or distance vision impairment; ~43 million blind",
    "numerator": 1,
    "denominator": 7,
    "unit": "of global adults who reach old age",
    "population": "global adults"
  },
  "normalized": {
    "lifetime_us_adult": 0.15,
    "display": "1 in ~7 lifetime (global adult)",
    "log_value": -0.82,
    "assumptions": "Uses the WHO Blindness and Vision Impairment fact sheet headline of ~2.2 billion people globally with near or distance vision impairment as the broad prevalence anchor, and the Vision Loss Expert Group (VLEG) / GBD 2019 Lancet Global Health paper (Steinmetz et al. 2021) for the narrower category of adults 50+ with blindness or moderate-to-severe distance vision impairment: 33.6 million blind and 206 million with MSVI in 2020 among adults 50+. Two complementary routes to a lifetime figure: (a) Direct prevalence: 2.2 billion / ~6 billion adults ≈ 37% point prevalence of any vision impairment, including uncorrected refractive error and presbyopia. Restricting to \"significant\" impairment (moderate-to-severe distance VI or blindness) gives ~240 million / ~2 billion adults 50+ ≈ 12% point prevalence in that age band, which is the direct anchor for the ~15% global lifetime figure once cumulative incidence across remaining lifespan is added. (b) Age-stratified: US VEHSS / CDC vision-health data indicate ~12 million US adults have some vision impairment and ~1 million are blind, and the age gradient is steep — under-65 rates are low, but among adults 80+, roughly 1 in 4 to 1 in 3 has significant vision loss. Naive compounding of age-specific hazards across an adult lifespan yields ~10-12% for US adults and ~15% globally. Headline 0.15 (≈ 1 in 7) with a wide uncertainty band of 0.10 to 0.22 to span the gap between the narrow \"US adult lifetime\" figure (~10-12%) and the broader \"global adult who lives to old age\" figure (~20-25%). Scope is global_adult_lifetime because cataract- driven vision loss is overwhelmingly concentrated in LMIC populations without surgical access, which pulls the global number meaningfully above the US-only figure.\n",
    "uncertainty": {
      "low": 0.1,
      "high": 0.22
    },
    "scope": "global_adult_lifetime"
  },
  "sources": [
    {
      "url": "https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment",
      "title": "Blindness and vision impairment — fact sheet",
      "publisher": "World Health Organization",
      "source_type": "govt_report",
      "statistic": "At least 2.2 billion people globally have a near or distance vision impairment; in at least 1 billion cases vision loss could have been prevented or is yet to be addressed; leading causes are refractive errors and cataracts; 1 in 2 people globally who need cataract surgery do not have access",
      "excerpt": "\"Globally, at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion of these, vision impairment could have been prevented or is yet to be addressed. [...] The leading causes of vision impairment and blindness are refractive errors and cataracts. [...] 1 in 2 people globally who need cataract surgery don't have access to that surgery.\"\n",
      "source_date": "2023-08-10",
      "source_accessed": "2026-04-11",
      "archive_url": "http://web.archive.org/web/20260413162956/https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment",
      "calculation_notes": "WHO's 2.2 billion / ~6 billion global adult population ≈ 37% point prevalence of *any* vision impairment, which is too broad for the \"significant\" framing (it includes presbyopia and uncorrected refractive error). The 1 billion preventable- or-unaddressed subset is the policy-relevant figure and the anchor for the ~90% avoidable claim in the long-form body. The single most load-bearing sentence is the \"1 in 2 people globally who need cataract surgery don't have access\" line, which establishes that the global number is partly a measure of healthcare access, not disease biology.\n",
      "independence_note": "WHO draws on upstream VLEG / GBD data for its fact-sheet headlines; treat as partially dependent with the Steinmetz et al. 2021 source below.\n"
    },
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7820391/",
      "title": "Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study",
      "publisher": "Lancet Global Health — GBD 2019 Blindness and Vision Impairment Collaborators (Steinmetz et al.)",
      "source_type": "peer_reviewed",
      "statistic": "33.6 million cases of global blindness and 206 million cases of moderate-to-severe vision impairment (MSVI) in adults aged 50+ in 2020; leading causes globally (blindness, adults 50+) were cataract (15.2M), glaucoma (3.6M), undercorrected refractive error (2.3M), age-related macular degeneration (1.8M), and diabetic retinopathy (0.86M)",
      "excerpt": "\"Global crude prevalence of 33·6 million cases of global blindness [in] adults aged 50 years and older in 2020. [...] 206 million aged 50 years and older adults with MSVI in 2020. [...] cataract (15·2 million cases), followed by glaucoma (3·6 million cases), undercorrected refractive error (2·3 million cases), age-related macular degeneration (1·8 million cases), diabetic retinopathy (0·86 million cases).\"\n",
      "source_date": "2020-12-01",
      "source_accessed": "2026-04-11",
      "archive_url": "https://web.archive.org/web/20260413163035/https://pmc.ncbi.nlm.nih.gov/articles/PMC7820391/",
      "calculation_notes": "Among adults aged 50+ (~2 billion globally), ~240 million have MSVI or blindness — a ~12% point prevalence in that age band. Since the 50+ hazard compounds across the remaining 30+ years of typical lifespan and shifts heavily upward above age 75, the cumulative lifetime incidence from mid-life onward is meaningfully higher than the cross-sectional point prevalence. This is the primary anchor for the 0.15 headline — it is also the source of the \"cataract is the single largest cause of global blindness\" claim that drives the treatability discussion in the body. Age-standardized rates of avoidable MSVI did not improve meaningfully over 2010-2019, so the WHO VISION 2020 target was missed; the absolute numbers grew because populations aged.\n",
      "independence_note": "This is the VLEG / GBD 2019 paper that the WHO fact sheet above ultimately cites; the two sources share an upstream and should be treated as partially dependent. The per-cause breakdown here is the methodologically primary statement; WHO is the policy summary.\n"
    },
    {
      "url": "https://www.cdc.gov/vision-health/about-eye-disorders/index.html",
      "title": "About Common Eye Disorders and Diseases",
      "publisher": "US Centers for Disease Control and Prevention",
      "source_type": "govt_report",
      "statistic": "~20.5 million Americans 40+ have cataract in one or both eyes; ~1.8 million Americans 40+ are affected by age-related macular degeneration; ~4.1 million Americans have diabetic retinopathy and 899,000 have vision-threatening retinopathy; cataract is the leading cause of vision loss in the US and diabetic retinopathy is the leading cause of blindness in working-age Americans",
      "excerpt": "\"An estimated 20.5 million (17.2%) Americans aged 40 years and older have cataract in one or both eyes. [...] About 1.8 million Americans aged 40 years and older are affected by AMD. [...] An estimated 4.1 million Americans have retinopathy and 899,000 have vision-threatening retinopathy. [...] Diabetic retinopathy (DR) is the leading cause of blindness in American adults of working age. [...] Cataract is [...] the leading cause of vision loss in the United States.\"\n",
      "source_date": "2024-05-15",
      "source_accessed": "2026-04-11",
      "archive_url": "https://web.archive.org/web/20260413163110/https://www.cdc.gov/vision-health/about-eye-disorders/index.html",
      "calculation_notes": "US-specific disease counts that collectively sum to roughly 12 million US adults with significant impairment (including uncorrected refractive error and presbyopia-adjacent conditions) and about 1 million legally blind. Used as the US anchor in regional_breakdown and to justify the ~1-in-10 US lifetime figure as a floor. The key distinction from the global number: the majority of US cataract is surgically corrected and does not progress to blindness, which is exactly what drives the gap between the US ~10% lifetime figure and the global ~15% figure.\n",
      "independence_note": "CDC Vision Health Initiative draws on the VEHSS (Vision and Eye Health Surveillance System) and NHANES, which are methodologically independent of the WHO / VLEG upstream; this is the independent US-side cross-check the schema asks for.\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "Death from Alzheimer's or other dementia (lifetime, global adult)",
      "lifetime_us_adult": 0.12
    },
    {
      "label": "Death from cancer (lifetime, global adult)",
      "lifetime_us_adult": 0.14
    },
    {
      "label": "Death from stroke (lifetime, global adult)",
      "lifetime_us_adult": 0.067
    },
    {
      "label": "Death in a car crash (lifetime, US)",
      "lifetime_us_adult": 0.0108
    },
    {
      "label": "Death in a plane crash (lifetime, US adult, regular flyer)",
      "lifetime_us_adult": 0.000017
    }
  ],
  "regional_breakdown": [
    {
      "region": "Global average, any significant adult-onset vision impairment",
      "probability": 0.15,
      "notes": "MSVI-or-blindness cumulative lifetime incidence; anchored on VLEG/GBD 2019 age-50+ prevalence"
    },
    {
      "region": "US adult lifetime",
      "probability": 0.12,
      "notes": "Roughly 12 million US adults with vision impairment and ~1 million blind; lifetime figure pulled down by near-universal cataract surgery access"
    },
    {
      "region": "LMIC — South Asia / Sub-Saharan Africa",
      "probability": 0.25,
      "notes": "Cataract dominates; almost entirely treatable with a single outpatient surgery — the global number is partly a healthcare-access measure, not disease biology"
    },
    {
      "region": "US adults 80+",
      "probability": 0.3,
      "notes": "Vision loss is heavily concentrated in the oldest decades; roughly 1 in 3 US adults 80+ has significant impairment"
    }
  ],
  "personal_factor_multipliers": [
    {
      "factor": "type 2 diabetes (25+ years)",
      "multiplier": 3,
      "notes": "Diabetic retinopathy is the leading cause of blindness in working-age American adults per CDC"
    },
    {
      "factor": "family history of AMD",
      "multiplier": 2,
      "notes": "First-degree relative with AMD roughly doubles individual risk"
    },
    {
      "factor": "current smoker",
      "multiplier": 2,
      "notes": "Smoking is the single largest modifiable risk factor for AMD and a meaningful risk factor for cataract progression"
    },
    {
      "factor": "regular dilated eye exams from age 50",
      "multiplier": 0.7,
      "notes": "Catches glaucoma and diabetic retinopathy at treatable stages; the risk reduction is about catching conditions early, not preventing their onset"
    }
  ],
  "short_label": "Vision loss",
  "myth_framing": "calibrated",
  "outcome_severity": "serious_harm",
  "exposure_pattern": "recurring",
  "outcome_type": "serious_permanent_harm",
  "valence": "negative",
  "caveats": "The single biggest interpretive issue on this entry is the \"preventable vs actually lost\" split. WHO estimates that vision loss could have been prevented or is yet to be addressed in roughly 1 billion of the 2.2 billion global cases, and the VLEG / GBD 2019 paper is clear that cataract — a condition that a single 15-minute outpatient surgery can almost entirely reverse — is the single largest cause of global blindness. The ~15% global figure therefore mixes truly lost vision (AMD, advanced glaucoma) with undertreated conditions whose cure is well-established and cheap. Treat this as two different numbers bundled into one statistic: a biological ceiling and a healthcare-access ceiling. The US figure (~10-12% lifetime) is closer to the biological ceiling because near-universal cataract surgery access removes the largest correctable cause from the denominator. The age gradient is also load-bearing: under-65 vision impairment rates are quite low, and the cumulative lifetime figure is heavily driven by what happens after 75. Anyone dying before their mid-70s from another cause never reaches peak vision-loss age, which is why the \"global average\" and \"US adults 80+\" rows in the regional breakdown differ by roughly a factor of two despite describing the same underlying hazard.\n",
  "quality_score": {
    "d1": 5,
    "d2": 5,
    "d3": 5,
    "d4": 5,
    "d5": 5,
    "d6": 4,
    "d7": 5,
    "d8": 4,
    "avg": 4.75,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-05-25",
    "methodology_version": "1.2"
  },
  "reviewer": "likelier-phase-5-agent",
  "last_reviewed": "2026-04-11",
  "reviewed": true,
  "generated_at": "2026-04-11",
  "image": {
    "alt": "A single pale circle softly out of focus against a muted grey-blue background, flat vector illustration."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/acquired-vision-loss"
}